Kvinder, som blev evalueret for incidens af vertebrale frakturer, modtog ikke samtidig osteporosebehandling, hvilket var tilladt for kvinder, som bidrog til evalueringerne af hoftefrakturer og alle kliniske frakturer.
Women who were evaluated for the incidence of vertebral fractures did not receive concomitant osteoporosis therapy, which was allowed for women contributing to the hip and all clinical fracture evaluations.